BSECompany Update5h ago · 1 Sept 2026, 03:49 pm
Conclusion of USFDA Inspection at Company''s Facilities situated at Visakhapatnam
Gland Pharma Ltd · 543245
✦ AI Summary▲ PositiveRegulatory
Gland Pharma Ltd has concluded the USFDA inspection at its facilities in Visakhapatnam, with zero observations. The inspection was conducted between August 22, 2022, and September 11, 2022, and was passed with zero Form 483 observations.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment9/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Conclusion Of USFDA Inspection At Company''s Facilities Situated At Visakhapatnam